TY - JOUR
T1 - Correction to
T2 - Relationship between ventilator-associated pneumonia and mortality in COVID-19 patients: a planned ancillary analysis of the coVAPid cohort (Critical Care, (2021), 25, 1, (177), 10.1186/s13054-021-03588-4)
AU - the coVAPid study group
AU - Nseir, Saad
AU - Martin-Loeches, Ignacio
AU - Povoa, Pedro
AU - Metzelard, Matthieu
AU - Du Cheyron, Damien
AU - Lambiotte, Fabien
AU - Tamion, Fabienne
AU - Labruyere, Marie
AU - Makris, Demosthenes
AU - Boulle Geronimi, Claire
AU - Pinetonde Chambrun, Marc
AU - Nyunga, Martine
AU - Pouly, Olivier
AU - Mégarbane, Bruno
AU - Saade, Anastasia
AU - Gomà, Gemma
AU - Magira, Eleni
AU - Llitjos, Jean François
AU - Torres, Antoni
AU - Ioannidou, Iliana
AU - Pierre, Alexandre
AU - Coelho, Luis
AU - Reignier, Jean
AU - Garot, Denis
AU - Kreitmann, Louis
AU - Baudel, Jean Luc
AU - Voiriot, Guillaume
AU - Contou, Damien
AU - Beurton, Alexandra
AU - Asfar, Pierre
AU - Boyer, Alexandre
AU - Thille, Arnaud W.
AU - Mekontso-Dessap, Armand
AU - Tsolaki, Vassiliki
AU - Vinsonneau, Christophe
AU - Floch, Pierre Edouard
AU - Le Guennec, Loïc
AU - Ceccato, Adrian
AU - Artigas, Antonio
AU - Bouchereau, Mathilde
AU - Labreuche, Julien
AU - Duhamel, Alain
AU - Rouzé, Anahita
AU - Favory, Raphaël
AU - Préau, Sébastien
AU - Jourdain, Mercé
AU - Poissy, Julien
AU - Leger, Piehr Saint
AU - Van der Linden, Thierry
AU - Cilloniz, Catia
N1 - Publisher Copyright:
© The Author(s) 2021
PY - 2021/12
Y1 - 2021/12
N2 - Following publication of the original article [1], the authors identified an error in the Abstract and Results section. The correct numbers and text are given hereafter. Abstract VAP was associated with significantly higher risk for 28-day mortality in SARS-CoV-2 group (adjusted HR 1.65 (95% CI 1.11–2.46), p = 0.013), but not in influenza (1.74 (0.99–3.06), p = 0.052), or no viral infection groups (1.13 (0.68–1.86), p = 0.63). Results Primary and secondary outcomes: VAP was associated with higher risk for 28-day mortality in in SARS-CoV-2 group, but not in the two other groups (Fig. 2A). All the changes that were requested are implemented in this correction and the original article [1] has been corrected.
AB - Following publication of the original article [1], the authors identified an error in the Abstract and Results section. The correct numbers and text are given hereafter. Abstract VAP was associated with significantly higher risk for 28-day mortality in SARS-CoV-2 group (adjusted HR 1.65 (95% CI 1.11–2.46), p = 0.013), but not in influenza (1.74 (0.99–3.06), p = 0.052), or no viral infection groups (1.13 (0.68–1.86), p = 0.63). Results Primary and secondary outcomes: VAP was associated with higher risk for 28-day mortality in in SARS-CoV-2 group, but not in the two other groups (Fig. 2A). All the changes that were requested are implemented in this correction and the original article [1] has been corrected.
UR - http://www.scopus.com/inward/record.url?scp=85112582450&partnerID=8YFLogxK
U2 - 10.1186/s13054-021-03713-3
DO - 10.1186/s13054-021-03713-3
M3 - Comment/debate
C2 - 34372897
AN - SCOPUS:85112582450
SN - 1364-8535
VL - 25
JO - Critical Care
JF - Critical Care
IS - 1
M1 - 284
ER -